Resource round-up: ECR Minerals, Bullabulling, Faroe Petroleum
Shares in ECR Minerals rose almost 4% after it drew the market's attention to the filing of a feasibility study on a copper flat in New Mexico. The company that owns the flat, THEMAC, is, in turn 19% owned by ECR. THEMAC now plans to begin the definitive feasibility mid-September 2012 and shortly afterwards begin work on detailed engineering.
Shares in ECR Minerals rose almost 4% after it drew the market's attention to the filing of a feasibility study on a copper flat in New Mexico. The company that owns the flat, THEMAC, is, in turn 19% owned by ECR. THEMAC now plans to begin the definitive feasibility mid-September 2012 and shortly afterwards begin work on detailed engineering.
Gold Miner Bullabulling pleased investors after it said results of a drilling programme showed better mineral resources than previously discovered at its Gold Project in Western Australia. The firm said a new resource estimate would be prepared with a moderate increase in contained ounces of gold anticipated. It shares rose 8% on the news.
Faroe Petroleum said it had acquired a 12.5% interest in the Darwin prospect in the PL531 licence in the Norwegian Barents Sea. It said multiple targets had been identified on 3D seismic tests and the first exploration well was expected to spud from the end December. The firm said the deal was an important step towards its ambition of building a strategic position in the Barents Sea.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
MM
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published